- Research areas
- HTA-methods & steering instruments
HTA-methods & steering instruments
The continued development of HTA-methods reflects the dynamic and diversity of medical research issues. Our methodological projects cover various activities, such as the design of different analytical tools, the focus on evaluation tools or ‘impact research’ on the usage of HTA-results, etc.
Research projects
Transparency: Sponsoring from patient initiatives, Update
Project leaders: Claudia Wild
Project team: Ozren Sehic
Duration: April 2021 –May 2021
AIHTA - Project „Transparency“
Telemonitoring in Austrian diabetes care: A systematic analysis of evaluation methodologies
Project leaders: Gregor Goetz
Project team: Gregor Goetz, Viktoria Hofer, Reinhard Jeindl
Duration: April 2021 to March 2022
Language: German (with English summary)
Publication: HTA Project Report No. 143: https://eprints.aihta.at/1370/
Process and evaluation of digital health applications in the context of “Symptom Checkers”
Project leaders: Reinhard Jeindl
Project team: Reinhard Jeindl, Gregor Goetz
Duration: April 2021 – November 2021
Language: German (with English summary)
Publication: HTA Project Report Nr. 141: https://eprints.aihta.at/1348/
Implementation aspects of expensive therapies: Coverage with real world data (RWD) collection using the example of SMA therapies
Project leaders: Claudia Wild
Project management part 1: Kathrin Wohlhöfner, Claudia Wild
Project management part 2: Judit Erdös, Claudia Wild
Project management part 3: Christoph Strohmaier, Judit Erdös, Claudia Wild
Duration: February to June (Part 1), July to August (Part 2), August to October (Part 3)
Language: English (with German summary)
Public & philanthropic financial contribution to the development of new drugs 2: EC-FP7 Health Projects
Project leaders: Claudia Wild
Project team: Louise Schmidt
Duration: July 2020 – January 2021
Language: English
Publikation: Journalartikel
Framework for reimbursement decisions of digital health technologies (mHealth) and its (retrospective) application on selected examples
Project leaders: Claudia Wild
Project team: Reinhard Jeindl, Claudia Wild
Duration: May 2020 – November 2020
Language: German (with English summary)
Publication: HTA Project report No. 134: https://eprints.aihta.at/1279
Evidence-based reimbursement processes in Europe Part 1: Reimbursement decisions for medical procedures in Austria. An analysis of factors – besides clinical evidence – influencing reimbursement decisions for the hospital benefit catalogue
Project leaders: Gregor Goetz
Project team: Gregor Goetz
Duration: September 2020 – November 2020
Language: English (with German summary)
Publication: https://bmchealthservres.biomedcentral.com/articles/
Technology Forecast: advanced therapies in late clinical research, EMA approval or clinical application via hospital exemption
Project leaders: Claudia Wild
Project team: Claudia Eder
Duration: August 2018 – November 2018
Language: English
Publication: Article
Public & philanthropic financial contribution to the development of new drugs 1: Methodology & 3 Case Studies
Project leaders: Claudia Wild
Project team: Louise Schmidt
Duration: February 2019 - May 2019
Language: English
Publications:
LBI-HTA Project report No. 120: https://eprints.aihta.at/1214/
Schmidt L, Wild C (2020): Assessing the public and philanthropic financial contribution to the development of new drugs: a bibliographic analysis. Science, Technology & Public Policy (STPP), 4 (1): 8-14.
Percutaneous aortic valve replacement in Austria (Part II): Data analysis
Project leaders: Martin Robausch
Project team: Martin Robausch, Robert Emprechtinger
Duration: Mai 2017 – November 2017
On behalf of the Federal States
Publication: LBI-HTA Project report No. 95b: https://eprints.aihta.at/1141/
